๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Second malignancy after treatment of childhood non-Hodgkin lymphoma

โœ Scribed by Wing Leung; John T. Sandlund; Melissa M. Hudson; Yinmei Zhou; Michael L. Hancock; Yunping Zhu; Raul C. Ribeiro; Jeffrey E. Rubnitz; Larry E. Kun; Bassem Razzouk; William E. Evans; Ching-Hon Pui


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
117 KB
Volume
92
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Second malignancies in non-Hodgkin's lym
โœ Brendan K. Macdougall; Brian H. Weinerman; Samuel Kemel ๐Ÿ“‚ Article ๐Ÿ“… 1981 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 309 KB ๐Ÿ‘ 2 views
Non-Hodgkin lymphoma (NHL) as a second n
โœ Siegert, Elke; Weissbach, Gerhard; Fischer, Rainer; Lauterbach, Ingrid ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 269 KB ๐Ÿ‘ 1 views

As far as we know, this is the first report of a non-Hodgkin lymphoma developing after successful treatment of neuroblastoma. A boy was found to have a mediastinal T-cell lymphoma at the age of 5. He had been treated for a neuroblastoma of the left adrenal region 4 years before, when by intensive ch

Growth and growth hormone secretion afte
โœ Samuelsson, Bengt O.; Mรกrky, Ildiko; Rosberg, Sten; Albertsson-Wikland, Kerstin ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 438 KB ๐Ÿ‘ 1 views

The aim of this study was to evaluate the centrations in 20-minute blood samples colgrowth and growth hormone (GH) secretion, as lected over a 24-hour period. The plasma GH assessed by the rate and pattern of secretion, in concentrations were transformed into GH secrepatients in remission from non-H

The treatment of non-Hodgkin's lymphoma
โœ Samuel Hellman; David S. Rosenthal; William C. Moloney; John T. Chaffey ๐Ÿ“‚ Article ๐Ÿ“… 1975 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 432 KB ๐Ÿ‘ 2 views

Much of the approach to evaluation and management of the non-Hodgkin's lymphomas has been modeled after Hodgkin's disease. However, as the name implies, they are quite different. The non-Hodgkin's lymphomas are a group of diseases and syndromes. These many different presentations, syndromes, and pos

Risk of second malignancy after cutaneou
โœ Arlene F. Kantor; Rochelle E. Curtis; Eric C. Vonderheid; Eugene J. van Scott; J ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 400 KB ๐Ÿ‘ 1 views

## Risk of second primary malignancy was assessed in a population-based follow-up survey of all persons who developed cutaneous T-cell lymphoma (CI'CL) in nine geographic areas of the United States covered by the Surveillance, Epidemiology and End Results (SEER) program of the National Cancer Inst